Paul Josephs - May 20, 2024 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Executive Officer, Director
Signature
/s/ Rebecca J Hilt Attorney-In-Fact for Paul Josephs
Stock symbol
LFCR
Transactions as of
May 20, 2024
Transactions value $
$0
Form type
4
Date filed
5/22/2024, 05:48 PM
Next filing
Dec 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +525K 525K May 20, 2024 Direct F1
transaction LFCR Common Stock Tax liability -8.98K -1.71% 516K May 20, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFCR Performance-Based Restricted Stock Units Award $0 +1.5M $0.00* 0 May 20, 2024 Common Stock 1.5M Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 Represents the maximum number of performance-based restricted stock units that can vest based on the Issuer's achievement of certain stock price milestones.
F4 The performance-based restricted stock units vest, if it all, based on the Issuer's achievement of certain stock prices.